## Why "Metabolism is dependent on hepatic CYP450 enzymes, leading to increased risk of systemic toxicity in liver disease" is right Amide local anesthetics (lidocaine, bupivacaine, ropivacaine, mepivacaine, prilocaine — identified by TWO "i's" before -caine) are metabolized by hepatic cytochrome P450 enzymes. In patients with liver disease, hepatic metabolism is impaired, leading to reduced drug clearance, accumulation, and increased risk of systemic toxicity (CNS and cardiac effects). This is a critical pharmacokinetic consideration that directly impacts dosing and safety in cirrhotic patients. (KD Tripathi 9e Ch 26) ## Why each distractor is wrong - **"Metabolism occurs via plasma cholinesterase, making the drug safer in hepatic impairment"**: This describes ESTER local anesthetics (procaine, cocaine, tetracaine, benzocaine — ONE "i"), not amides. Ester metabolism by plasma cholinesterase is independent of liver function, but the question specifically asks about amide linkage (B). - **"The drug is rapidly excreted unchanged in urine, independent of liver function"**: Amide local anesthetics undergo hepatic metabolism; they are not excreted unchanged in significant amounts. This is factually incorrect and ignores the CYP450 dependence. - **"Allergic reactions are common due to para-aminobenzoic acid (PABA) metabolites produced in the liver"**: PABA is the allergenic metabolite of ESTER local anesthetics, not amides. Amide local anesthetics have RARE allergic reactions (usually due to preservatives like methylparaben, not the drug itself). **High-Yield:** Amides = hepatic CYP450 metabolism (caution in liver disease); Esters = plasma cholinesterase hydrolysis (PABA allergen, more allergic reactions). [cite: KD Tripathi 9e Ch 26]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.